Astellas Reports The First Nine Months Financial Results Of FY2016

January 31, 2017 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TOKYO--(BUSINESS WIRE)--Astellas Pharma Inc. (TOKYO: 4503) (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced financial results for three quarters of fiscal year 2016 ending March 31, 2017 (“FY2016”).

Twitter
LinkedIn
Facebook
Email
Print

Earnings Asia

Astellas Pharma US, Inc.